Back to all Programs

Past Event

Related Materials

Past Event

International Hepatitis Cure & Eradication Meeting 2015

The Toronto Declaration - Where are we now? - Jordan Feld, MD, MPH

Hepatitis C Vaccines: Are we making progress? - Christopher M. Walker, PhD

A hepatitis C Vaccine: How do we prove it works? - Kimberly Page

Point-of-care (POC) testing in Hepatitis B and C - Scott Bowden, PhD

Hepatitis B Vaccine: Optimizing coverage and efficacy - Alex Vorsters, PhD

Baby Boomer Screening in the U.S: Delivering on the promise thus far? - John Ward, MD

New Treatment Strategies for Hepatitis B - Harry Janssen, MD, PhD

New tools for testing and monitoring Hepatitis B and C - Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)

Maximizing SVR with current HCV therapy - Alnoor Ramji, MD, FRCP

New Treatment in HCV: Is there need for more therapies? - Jordan Feld, MD, MPH

Hepatitis C treatment in resource-limited countries - Gamal Esmat, MD

Perspective from health economics - David Rein, PhD

Perspective from Civil Society - Tracy Swan

Perspective from Payers - Mel Krajden, MD, FRCPC & Bonnie Henry, MD, MPH, FRCPC

Perspective from Medical Community - Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD

Rational pricing and the role of generics - Raymond Schinazi, PhD, DSc